Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
vercirnon (GSK1605786) (formerly CCX282-B, Traficet-EN)
Also known as: 1605786, GSK786
print preview
bookmark
share with colleague
General Information
Company
ChemoCentryx Inc.
Description
CC chemokine receptor 9 (CCR9) antagonist
Molecular Target
CC chemokine receptor 9 (CCR9) (CDw199)
Mechanism of Action
CC chemokine receptor 9 (CCR9) antagonist
Latest Stage of Development
Phase III
Indication
Crohn's disease
Partner
GlaxoSmithKline plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy